An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2026 Jan-.
Top results in this bookTable of Contents
Management of Uterine Fibroids [Internet].
Hartmann KE, Fonnesbeck C, Surawicz T, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Dec. (Comparative Effectiveness Review, No. 195.)
Ulipristal Acetate (Fibristal) (5 mg Tablets): Treatment of Moderate to Severe Signs and Symptoms of Uterine Fibroids in Adult Women of Reproductive Age Who are Eligible for Surgery. The Duration of Treatment is Limited to Three Months [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2013 Dec.
Uterine-Preserving Interventions for the Management of Symptomatic Uterine Fibroids: A Systematic Review of Clinical and Cost-Effectiveness [Internet].
Chen S, Pitre E, Kaunelis D, et al.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Jan.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Comparative Oncology.
Baba AI, Câtoi C.
Bucharest (RO): The Publishing House of the Romanian Academy; 2007.
Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding: the UCON randomised controlled trial and mechanism of action study.
Whitaker LHR, Middleton LJ, Priest L, et al.
Southampton (UK): National Institute for Health and Care Research; 2023 Oct. (Efficacy and Mechanism Evaluation, No. 10.08.)
Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT.
Daniels J, Middleton LJ, Cheed V, et al.
Southampton (UK): National Institute for Health and Care Research; 2022 Apr. (Health Technology Assessment, No. 26.22.)
GeneReviews® [Internet].
Adam MP, Bick S, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2026.
Cost-effectiveness of diagnostic strategies for the management of abnormal uterine bleeding (heavy menstrual bleeding and post-menopausal bleeding): a decision analysis.
Cooper NAM, Barton PM, Breijer M, et al.
Southampton (UK): NIHR Journals Library; 2014 Apr. (Health Technology Assessment, No. 18.24.)
Relugolix-Estradiol–Norethindrone Acetate (Myfembree): Therapeutic area: Management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women: Reimbursement Review [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2026 Jan.
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
Diseases of the Abdomen and Pelvis 2018-2021: Diagnostic Imaging - IDKD Book [Internet].
Hodler J, Kubik-Huch RA, von Schulthess GK, editors.
Cham (CH): Springer; 2018.
Holland-Frei Cancer Medicine. 6th edition.
Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.
Hamilton (ON): BC Decker; 2003.
Evidence reviews for diagnostic test accuracy in investigation for women presenting with heavy menstrual bleeding: Heavy menstrual bleeding (update): Evidence review A.
National Guideline Alliance (UK).
London: National Institute for Health and Care Excellence (NICE); 2018 Mar. (NICE Guideline, No. 88.)
CADTH Canadian Drug Expert Committee Recommendation: Ulipristal Acetate (Fibristal — Allergan Inc.): Indication: Uterine fibroids [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Nov.
InformedHealth.org [Internet].
Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-.
Surgical Treatment: Evidence-Based and Problem-Oriented.
Holzheimer RG, Mannick JA, editors.
Munich: Zuckschwerdt; 2001.
Evaluating the Potential Use of Modeling and Value-of-Information Analysis for Future Research Prioritization Within the Evidence-Based Practice Center Program [Internet].
Myers E, Sanders GD, Ravi D, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Jun. (Methods Future Research Needs Reports, No. 5.)
Endotext [Internet].
Feingold KR, Adler RA, Ahmed SF, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on